Alebund (Jiangsu)

Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018. We are a global leading biopharmaceutical company focused on the field of nephrology. According to CIC Consulting, we possess the most comprehensive portfolio of innovative nephrology products with the widest range of indications. The CKD market is vast, valued at hundreds of billions of dollars, and holds tremendous growth potential. We have built a vertically integrated platform covering R&D, manufacturing, and commercialization. Starting with hyperphosphatemia, we have now expanded into the entire nephrology field. By providing innovative therapies for kidney diseases, we not only help elevate current treatment standards but also address unmet medical needs for patients whose lives have been altered by kidney disease.